POLE and neoplasm: The coexistence of MSI+ and mutated POLE may be associated with higher densities of CD8+ TILs, PD-1-expressing CD8+ TILs, and tumor-infiltrating immune cells with a Th1 phenotype in the TME, strongly predicting response to checkpoint inhibitors (102).